Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores

Affiliations

¹ Department of Medicine, Endocrinology and Metabolism, University of Verona, Verona, Veneto, Italy giovanni.targher@univr.it zhengmh@wmu.edu.cn.
² Department of Medicine, Endocrinology and Metabolism, University of Verona, Verona, Veneto, Italy.
³ Southampton National Institute for Health Research Biomedical Research Centre, Southampton General Hospital, Southampton, Hampshire, UK.
⁴ Department of Critical Care Medicine, Wenzhou Medical College First Affiliated Hospital, Wenzhou, Zhejiang, China.
⁵ Department of Hepatology, Ningbo No 2 Hospital, Ningbo, Zhejiang, China.
⁶ Department of Radiology, Wenzhou Medical University First Affiliated Hospital, Wenzhou, Zhejiang, China.
⁷ NAFLD Research Center, Department of Hepatology, Wenzhou Medical College First Affiliated Hospital, Wenzhou, Zhejiang, China.
⁸ Department of Infection and Liver Diseases, Liver Research Center, Wenzhou Medical College First Affiliated Hospital, Wenzhou, Zhejiang, China.
⁹ Storr Liver Centre, Westmead Institute for Medical Research, Westmead, New South Wales, Australia.
¹⁰ NAFLD Research Center, Department of Hepatology, Wenzhou Medical College First Affiliated Hospital, Wenzhou, Zhejiang, China giovanni.targher@univr.it zhengmh@wmu.edu.cn.
¹¹ Institute of Hepatology, Wenzhou Medical University, Wenzhou, Zhejiang, China.

Comment

Giovanni Targher et al. Gut. 2020 Aug.

. 2020 Aug;69(8):1545-1547.

doi: 10.1136/gutjnl-2020-321611. Epub 2020 May 15.

¹ Department of Medicine, Endocrinology and Metabolism, University of Verona, Verona, Veneto, Italy giovanni.targher@univr.it zhengmh@wmu.edu.cn.
² Department of Medicine, Endocrinology and Metabolism, University of Verona, Verona, Veneto, Italy.
³ Southampton National Institute for Health Research Biomedical Research Centre, Southampton General Hospital, Southampton, Hampshire, UK.
⁴ Department of Critical Care Medicine, Wenzhou Medical College First Affiliated Hospital, Wenzhou, Zhejiang, China.
⁵ Department of Hepatology, Ningbo No 2 Hospital, Ningbo, Zhejiang, China.
⁶ Department of Radiology, Wenzhou Medical University First Affiliated Hospital, Wenzhou, Zhejiang, China.
⁷ NAFLD Research Center, Department of Hepatology, Wenzhou Medical College First Affiliated Hospital, Wenzhou, Zhejiang, China.
⁸ Department of Infection and Liver Diseases, Liver Research Center, Wenzhou Medical College First Affiliated Hospital, Wenzhou, Zhejiang, China.
⁹ Storr Liver Centre, Westmead Institute for Medical Research, Westmead, New South Wales, Australia.
¹⁰ NAFLD Research Center, Department of Hepatology, Wenzhou Medical College First Affiliated Hospital, Wenzhou, Zhejiang, China giovanni.targher@univr.it zhengmh@wmu.edu.cn.
¹¹ Institute of Hepatology, Wenzhou Medical University, Wenzhou, Zhejiang, China.

No abstract available

Keywords: nonalcoholic steatohepatitis.

Conflict of interest statement

Competing interests: None declared.

Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study.
Ji D, Qin E, Xu J, Zhang D, Cheng G, Wang Y, Lau G. Ji D, et al. J Hepatol. 2020 Aug;73(2):451-453. doi: 10.1016/j.jhep.2020.03.044. Epub 2020 Apr 8. J Hepatol. 2020. PMID: 32278005 Free PMC article. No abstract available.